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The solution conformation of the recently discovered b&cyclic, 21 amino acid vasoconstrictor peptide, Endothelin I, has been examined by ‘H-NMR 
in deuterated imethyl sulphoxide. A full sequential assignment has been achieved. In addition, 19 long range NOES were detected which were 
employed as distance constraints in molecular dynamics calculations to yield a possible solution structure for this new peptide. 
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1. INTRODUCTION 
Endothelin is a bi-cyclic, 21 amino acid vasoconstric- 
tor peptide recently isolated and characterized from 
cultured porcine aortic endothelial cells [ 11. Recent 
pharmacological studies have shown that endothelin 
exerts a wide range of biological effects, in addition to 
its potent vasoconstrictor activity [2-51. Moreover, en- 
dothelin now appears to be but one (Endothelin I) in a 
family of endothelin-like peptides which have a similar 
overall structure but different amino acid sequences 
[6]. In view of the expanding role that the endothelins 
appear to play in reguIation of various mammalian 
systems, we have examined the ‘H-NMR spectral pro- 
perties of Endothelin I in dimethyl sulphoxide so as to 
better understand the conformational features impor- 
tant for its interaction with membrane receptors. In this 
report, we present the complete sequence-specific 
assignment of the ‘H-NMR spectrum and a possible 3D 
structure derived from these data using molecular 
modeling techniques. 
2. MATERIALS AND METHODS 
2.1. Peptide synthesis 
Endothelin was synthesized by standard solid-phase synthetic 
techniques using an automated peptide synthesizer and Boc-Trp- 
PAM resin [7,8]. Cysteines at positions 1 and 15 were protected by 
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4-methylbenzyl, while the cysteines at positions 3 and 11 were pro- 
tected by acetamidomethyl. The peptide was deprotected (except he 
Acm groups on Cys 3 and 11) and removed from the resin with the 
two-step ‘low-high’ HF method [9]. After cyclization with 0.01 M 
K,Fe(CN)6 at pH 8.5 [lo], the mono-cyclic analog was purified by gel 
filtration and preparative reverse-phase HPLC. The purified 
[Cys(Acm)3.“]Endothelin (FAB-MS [MH]+ = 2635.36, talc. = 
2635.31) was reacted with HgOAc for 1 h, the mercuric salts removed 
with one equivalent ,Y-mercaptoethanol in 30% acetic acid, and the 
peptide cyclized as before. The synthetic endothelin had an identical 
retention time on analytical Cls reverse-phase HPLC as a commercial 
sample (NOVA Biochem, Switzerland). Amino acid analysis after 
acid hydrolysis gave the proper molar ratios (f 7.0%) of the consti- 
tuent amino acids; FAB-MS [MH]+ = 2491.00, talc. = 2491.06. 
2.2. NMR spectroscopy 
Endothelin was dissolved in deuterated dimethyl sulphoxide 
(isotopic purity 99.96%) to a concentration of approximately 
3.5 mM. Experiments were performed at 500 MHz, 37”C, on a 
Bruker AM500 spectrometer. A standard set ill] of two-dimensional 
phase sensitive spectra was obtained: correlated (COSY) [12], double 
quantum filtered correlated (DQF-COSY) [13], relayed coherence 
transfer (RELAY) [14] and nuclear Overhauser enhancement 
(NOESY) [15]. The data-sets were recorded in 2K blocks in the se- 
cond time domain and in 0.5K blocks in the first domain. A total of 
32 transients with 1.5 s relaxation delay between them were acquired 
at each increment. Spectra were processed on a Bruker X32 process- 
ing station with UXNMR Bruker program. Gaussian and shifted 
sine-bell functions were applied for apodisation. After zero-filling to 
4K and 2K in the second and first dimensions, the digital resolution 
was 2.94 Hz/point and 5.88 Hz/point, respectively. The base-line of 
the spectra was corrected by fitting a third degree polynomial in both 
dimensions. In order to minimize the spin-diffusion effects, build-up 
of the nuclear Overhauser enhancement (NOE) was followed in the 
range of 150-500 ms. The chemical shift was referenced to 
3-(trimethylsilyl)propionic-2,2,3,3-d4 acid. The Brookhaven 
databank notation is used for the amino acid atoms (e.g. HA, HB, 
HG, etc. stands for the (r-, &, y- etc. hydrogens). 
2.3. Molecular modeling 
SYBYL [16] and AMBER [17] programs were used for molecular 
mechanics/molecular dynamics calculations. Dynamics routines were 
00145793/89/$3.50 0 1989 Federation of European Biochemical Societies 145 
Volume 257, number 1 FEBS LETTERS October 1989 
0 $$ c3 
a.5 8.0 15 
F2 (ppm) 
._ 
I .‘. 3 , , , , , , 
8.5 8.0 75 
F2 (ppm) 
4.0 
4.2 -n 
0 
4.4 ; 
4.6 
Fig.1. The fingerprint region of the spectra of endothelin showing 
cross-peaks between HA and HN resonances. (A) COSY spectrum. 
Cross-peaks of Cl, S2, S4 and D8 were not detected. The position of 
D4 and D8 (represented by a dashed line box) were identified in the 
corresponding NOESY spectrum (B). C3 cross-peak (solid-line) is 
plotted at one contour level lower than the rest of the spectrum. (B) 
NOESY spectrum. HAi/HNi cross-peaks corresponding to the COSY 
peaks in A are boxed. The lines indicate the sequential connectivities 
by which the HAi/HNi and HAi+r/HNi+r cross-peaks are connected 
via a sequential cross-peak HAi/HNi+r. The dashed lines represent 
undetected connectivities. 
performed for 60 ps at 300 K, with conformations stored at 0.05 ps 
intervals. No periodic boundary conditions were applied, and the 
calculations were performed in the gas phase. Distance constraints 
for long range NOES were entered as internal bond constraints with 
force constants of 20 kcal. All long range NOES were translated to 
an upper limit distance of 0.5 nm to which were added the ap- 
propriate pseudo atom correction distances 111). These values were 
then employed as upperbound values in the molecular dynamics 
calculations. 
3. RESULTS AND DISCUSSION 
A full sequential assignment was achieved using the 
two-stage strategy of Wuthrich [ll]. A sufficient 
number of amino acid spin systems could be 
distinguished from the COSY and RELAY spectra to 
follow the sequence in the amide part of the spectrum. 
Fig. 1 illustrates the sequential connectivity delineation 
between the HAi and HAi+ 1. All main-chain sequential 
NOES are summarized in table 1. The sequence could 
Table 1 
The sequence of endothelin (SS bridges: Cl-Cl5 and C3-Cll) with 
a summary of the sequential connectivities 
I 5 IO 15 M 
CSCSSLMDKECVYFCHLDIIW 
a/N, /3/N and N/N stand respectively for HAi/HNi+r, HBi/HNi+, 
and HNJHNi+r. The symbol means that the NOE could not be 
detected because it was obscured by a stronger signal or that the 
chemical shift of the two resonances involved is nearly identical. The 
height of the bar indicates the intensity of the detected NOE 
be followed almost entirely via HAJHNi+ 1, 
HBi/HNi+ 1 and partly via HNJHNi+ 1 cross peaks. The 
analysis of the spectra thus allowed us to gain full se- 
quential assignment of all ‘H-NMR resonances 
detected (table 2). All aliphatic and aromatic hydrogens 
and all but two amide hydrogens (first two in the se- 
quence) gave a detectable NMR signal. 
Despite the low molecular mass of endothelin 
(-2500 Da), a large number of NOES were recorded 
which were all negative. In addition to sequential 
NOES, 19 long range NOES were also detected (table 3). 
Furthermore, a significant spread in the chemical shifts 
Table 2 
‘H-NMR assignments of endothelin in dimethylsulfoxide 
Sequence Resonances 
residue 
HN HA HB Others 
No. 
1 c 3.75 2.87 3.01 
2 s 4.46 3.63 
3 C 8.23 4.77 2.87 3.18 
4 S 8.78 4.42 3.62 3.72 
5 S 8.09 4.36 3.64 3.83 
6 L 8.10 4.21 4.58 1.65HG 0.84, 0.89HD 
7 M 7.44 4.30 1.87 2.04 2.42, 2.52HG 2.07HD 
8 D 7.52 4.42 2.60 2.81 
9 K 8.55 4.03 1.61 1.79 1.4HG 1.53HD 2.78HE 
10 E 8.17 4.23 1.89 2.27 2.38HG 
11 C 8.33 4.53 2.93 3.10 
12 v 7.73 3.97 1.94 0.74, 0.76HG 
13 Y 7.63 4.32 2.66 2.79 6.93HD 6.59HE 
14 F 7.90 4.57 2.88 3.12 7.23HD 7.17HE + HZ 
15 C 8.13 4.58 2.98 3.12 
16 H 7.98 4.47 2.93 3.12 7.58HEl 6.84HD2 
17 L 7.87 4.26 4.56 1.55HG 0.81, 0.84HD 
18 D 8.62 4.62 2.50 2.78 
19 I 7.43 4.22 1.69 1.38HGl 1.02HG2 0.75HD 
20 I 7.70 4.21 1.72 1.4lHGl 1.07HG2 0.8HD 
21 W 8.02 3.05 3.15 10.76HDl 7.13HDl 7.25HE3 
5.98HZ3 7.06HH3 7.33822 
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Table 3 
Summary of NOES detected between sequentially remote residues of 
endothelin 
Residue Resonance Residue Resonance 
cys' 
cys’ 
Se? 
cys’ 
cyss 
Se8 
Ser’ 
Lys9 
Val” 
Val’* 
Val’* 
Tyr13 
Phe14 
Phe14 
Phe14 
Phe14 
HisI 
His16 
BeI 
HA 
HA 
HA 
HA 
HA 
HA 
HB 
HA 
HA 
HG 
HB 
HD (ortho) 
HD 
HD 
HD 
HD 
HD 
HD 
HG2 
Cys’S 
c# 
cys” 
cys” 
Set5 
cys” 
Val” 
Val” 
cys’5 
Trp” 
Phe14 
Phe14 
Val” 
Leu” 
Ile19 
Be” 
BeI 
Be*’ 
Trp2’ 
HA 
HB 
HB 
HB 
HA 
HB 
HG 
HG 
HB 
HB 
HD 
HD 
HB 
HG:(:H$ 
HG2 
HG2 
HG2 
HZ1 
was observed (table 1; note for example, the very dif- 
ferent chemical shift of all four cysteine residues). Both 
of these results suggest that endothelin assumes an 
ordered conformation in solution. 
terminal hexapeptide in an extended random coil con- 
formation, was generated in the following way: (i) con- 
struction of the peptide by sequentially adding amino 
acid building blocks; (ii) addition of the two disulfide 
bonds followed by energy minimization. In the 
molecular dynamics calculations, NMR experimental 
constrains were introduced. All long range NOES (table 
3) were translated to an upper limit distance of 0.5 nm 
with pseudo atom correction [l 11. Further precision 
was not attempted ue to uncertainty in the dependence 
of the mixing time (range 150-500 ms) on NOE intensi- 
ty. All NOES were, however, clearly detectable at mix- 
ing times of 300 ms or higher. Molecular dynamics 
calculations yield a series of very closely related com- 
pact structures in which the C-terminal hexapeptide is 
associated with the bi-cyclic portion of the molecule. 
The averaged structure for the last 400 conformations 
generated in the dynamics run (20 ps) was calculated 
and energy minimized to remove discrepancies due to 
averaging. The sequential NOES, which were not 
employed as constraints in the molecular dynamics 
calculations, were now used to examine the minimized, 
averaged molecule. The final structure (fig.2) agrees 
with all the NMR data to within 0.03 nm. RMS devia- 
tions for all backbone atoms in the final 20 ps (400 con- 
formations) are also less than 0.3 nm compared to the 
averaged, minimized structure. 
To examine the solution conformation(s) more Although considerable uncertainty in the conforma- 
carefully, a series of molecular energy calculations were tions of the individual amino acid side-chains exists, the 
performed. A suitable starting structure, with the C- NOE data and the molecular dynamics studies define 
Fig.2. Stereoview of the solution conformation of Endothelin I in DMSO from NMR and molecular modeling studies. 
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the peptide backbone structure except for the dihedral 
angle of the two disulfide bonds. Assuming a standard 
dihedral angle of either f 90” [18], Endothelin I may 
exist in any of 4 possible conformations. Molecular 
modeling studies indicate that the present NOE data are 
not sufficient to unambiguously define these two 
angles. Nevertheless, the structure shown in fig.2, with 
dihedral angles of -90” (Cysi-Cys”) and +90” 
(Cys3-Cys”), is in best agreement with our results. 
4. CONCLUSIONS 
The ‘H-NMR spectrum of endothelin in deuterated 
DMSO has been fully assigned. The NOE spectra were 
utilized to provide 19 distance constraints that formed 
the basis for the modeling experiments and the deter- 
mination of a possible solution structure (fig.2). While 
additional biophysical studies will be necessary to more 
completely define side-chain conformations, the pre- 
sent study shows that endothelin assumes a compact 
conformation in DMSO with the linear C-terminal hex- 
apeptide closely associated with the bi-cyclic part of the 
molecule. 
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